Dáil Éireann Debate, Wednesday - 6 June 2012
841 Deputy Billy Kelleher asked the Minister for Health when he expects to introduce reference pricing and generic substitution; the likely savings in a full year; the work completed on the legislation up to February 2011; the rate of generic prescribing here now and the likely increase once the legislation is introduced; and if he will make a statement on the matter. [26265/12]
View answerThe Health (Pricing and Supply of Medical Goods) Bill 2012 is on the list of Bills to be published in this session of Dail Eireann. This legislation will introduce a system of reference pricing and generic substitution for prescribed drugs and medicines. These reforms will promote price competition among suppliers and ensure that lower prices are paid for these medicines resulting in savings for taxpayers and patients. The rate of generic prescribing in Ireland is approximately 18%. It is envisaged that the proposed legislation will contribute to an increase in this rate. It is not possible, at this juncture, to provide accurate figures regarding potential savings resulting from reference pricing, as these depend on various factors including prevailing prices, number of competitors, availability of substitute products, and market dynamics.
